Special Issue "Antidiabetic Drugs"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 June 2010)
Prof. Dr. Kailash Prasad
Department of Physiology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
Phone: +1 306 966 6539
Interests: Oxygen radicals, antioxidants, heart failure, atherosclerosis, diabetes, flaxseed and its components, hypertension, hypercholesterolemia, acute coronary syndrome, advanced glycation end products, soluble receptor for advanced glycation end products, C-reactive protein, homocysteine, cytokines, phosphoenolpyruvate carboxykinase
All manuscripts should be submitted to firstname.lastname@example.org with a copy to the Guest Editor. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access monthly journal published by MDPI.
- glucagon-like peptide (GLP) analogs and agonists
- DPP-4 inhibitors
- amylin analogues
- gastric inhibitory peptide (GIP) analogs
Pharmaceuticals 2010, 3(3), 764-781; doi:10.3390/ph3030764
Received: 15 January 2010; in revised form: 3 March 2010 / Accepted: 19 March 2010 / Published: 22 March 2010| Download PDF Full-text (1095 KB) | Download XML Full-text
Pharmaceuticals 2010, 3(8), 2554-2567; doi:10.3390/ph3082554
Received: 2 July 2010; in revised form: 5 August 2010 / Accepted: 9 August 2010 / Published: 11 August 2010| Download PDF Full-text (141 KB)
Pharmaceuticals 2010, 3(8), 2610-2646; doi:10.3390/ph3082610
Received: 14 July 2010; in revised form: 9 August 2010 / Accepted: 10 August 2010 / Published: 13 August 2010| Download PDF Full-text (237 KB)
Review: Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action
Pharmaceuticals 2010, 3(9), 3005-3020; doi:10.3390/ph3093005
Received: 29 July 2010; in revised form: 3 September 2010 / Accepted: 6 September 2010 / Published: 15 September 2010| Download PDF Full-text (165 KB)
Last update: 13 August 2010